Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NECTAR LIFESCIENCE Gains 8%; BSE HEALTHCARE Index Up 0.6%
Tue, 27 Aug 9:53

NECTAR LIFESCIENCE Gains 8%; BSE HEALTHCARE Index Up 0.6%Image source: Eoneren/www.istockphoto.com

NECTAR LIFESCIENCE share price has zoomed 8% and is presently trading at Rs 41.5.

Meanwhile, the BSE HEALTHCARE index is at 42,404.8 (up 0.6%).

Among the top gainers in the BSE HEALTHCARE index today are Jubilant Pharmova (up 3.1%) and Pfizer (up 2.5%).

ASTER DM HEALTHCARE (down 0.8%) and POLY MEDICURE (down 0.6%) are among the top losers today.

Over the last one year, NECTAR LIFESCIENCE has moved up from Rs 25.5 to Rs 41.5, registering a gain of Rs 16.0 (up 62.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,099.5 to 42,404.8, registering a gain of 50.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 130.8%), Glenmark Pharma (up 125.5%) and SUVEN PHARMACEUTICALS (up 110.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,655.3 (down 0.1%).

The top losers among the BSE Sensex today are JSW Steel (down 1.2%) and Kotak Bank (down 0.8%). The most traded stocks in the BSE Sensex are Tata Steel and HCl Tech..

In the meantime, NSE Nifty is at 24,995.9 (down 0.1%). BPCL and Shriram Transport are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,433.3 to 81,655.3, registering a gain of 16,222.0 points (up 24.8%).

NECTAR LIFESCIENCE Financial Update...

NECTAR LIFESCIENCE net profit grew 63.1% YoY to Rs 30 million for the quarter ended June 2024, compared to a profit of Rs 18 million a year ago. Net sales declined 8.8% to Rs 3,593 million during the period as against Rs 3,941 million in April-June 2023.

For the year ended March 2024, NECTAR LIFESCIENCE reported 120.7% increase in net profit to Rs 50 million compared to net loss of Rs 242 million during FY23. Revenue of the company grew 10.9% to Rs 14,423 million during FY24.

The current Price to earnings ratio of NECTAR LIFESCIENCE, based on rolling 12 month earnings, stands at 151.5.


Equitymaster requests your view! Post a comment on "NECTAR LIFESCIENCE Gains 8%; BSE HEALTHCARE Index Up 0.6%". Click here!